Active
TERM 2
May 2026 · 62 days ago
🏥 Healthcare
Health Secretary Robert F. Kennedy Jr. terminated the two vice chairs of the U.S. Preventive Services Task Force (USPSTF) on May 11, 2026, removing influential leaders from the panel that determines which preventive medical services insurers must cover without cost. The firings remove independent oversight from decisions affecting millions of Americans' access to free preventive care including screenings and vaccinations. The action reflects the administration's pattern of dismantling independent health agencies and scientific advisory bodies.
Active
TERM 2
May 2026 · 67 days ago
🏥 Healthcare
The Trump administration announced it would withhold $1.3 billion in Medicaid payments to California, citing insufficient state efforts to combat fraud in the public health insurance program. Vice President JD Vance justified the action as necessary to address waste in the program. The withholding directly impacts California's ability to fund Medicaid services and affects millions of beneficiaries relying on the state's healthcare coverage.
Active
TERM 2
January 2025 · 68 days ago
🏥 Healthcare
A federal appeals court ruled to eliminate telehealth prescribing of mifepristone, a common medication used for abortion and miscarriage care. This action makes it harder for Americans to access the medication and represents a step toward broader abortion restrictions. The decision was made on legal grounds rather than new safety evidence.
Active
TERM 2
January 2025 · 68 days ago
🏥 Healthcare
The FDA authorized fruit-flavored vapes for adult consumers, reversing years of aggressive regulatory efforts to restrict flavored vaping products. The decision followed pressure from President Trump on FDA leadership. This move eliminates restrictions on flavored e-cigarettes that had been in place to discourage youth vaping.
Pending
TERM 2
January 20 2025 · 75 days ago
🏥 Healthcare
A Trump administration regulation will reduce federal assistance for disabled young adults who live with their parents or family members. The policy penalizes disabled individuals for maintaining family living arrangements that help them stay in their homes. This directly impacts disabled Americans' access to crucial support services and ability to live independently or with family support.
Active
TERM 2
January 20 2025 · 88 days ago
🏥 Healthcare
The Trump administration's changes to CDC vaccine guidance resulted in the loss of recommendations for several vaccines including flu and Covid shots. A judge's stay on these changes created uncertainty about vaccine access in some states, while a halted vaccines committee prevents new recommendations from being made. This directly impacts Americans' access to preventive vaccines and future vaccine development.
Active
TERM 2
April 9, 2026 · 94 days ago
🏥 Healthcare
The Trump administration redirected the Title X family planning program to de-emphasize hormonal birth control provision at health clinics. This policy shift changes the program's core focus despite clinics receiving delayed funding. The change directly impacts women's access to contraception through federally-funded clinics nationwide.
Active
TERM 2
April 2026 · 101 days ago
🏥 Healthcare
The Trump administration announced 100% tariffs on patented drugs to force pharmaceutical companies into pricing negotiations and shift manufacturing to America. This action leverages tariff threats to compel drugmakers into 'most-favored nation' pricing deals. The policy directly impacts drug prices and availability for American consumers while pressuring companies to relocate production domestically.
Active
TERM 2
August 13 2025 · 333 days ago
🏥 Healthcare
Executive Order 14336 directs the establishment and filling of a Strategic Active Pharmaceutical Ingredients Reserve to strengthen domestic pharmaceutical supply chains. The order aims to reduce U.S. dependence on foreign sources for critical drug components and improve resilience against supply disruptions. Americans may see increased availability and potentially lower costs for essential medications through enhanced domestic pharmaceutical production capacity.
Active
TERM 2
May 2025 · 410 days ago
🏥 Healthcare
The Drug Enforcement Administration announced plans to temporarily classify 7-hydroxymitragynine (7-OH) and three related kratom-derived compounds as Schedule I controlled substances, placing them in the same category as heroin and LSD. The action would eliminate legal access to products containing these substances and criminalize possession. The policy affects thousands of Americans who use kratom products for pain management and wellness purposes.